NYSE: NVO
Novo Nordisk A S Stock

Overview

Forecast Earnings Dividend Ownership

NVO Price

$73.18

Fair Value Price

N/A

Market Cap

$172.55B

52 Week Low

$49.24

52 Week High

$73.92

P/E

25.55x

P/B

18.54x

P/S

8.38x

PEG

3.14x

Dividend Yield

1.78%

Revenue

$19.54B

Earnings

$6.72B

Gross Margin

83.7%

Operating Margin

44.9%

Profit Margin

34.4%

Debt to Equity

1.35

Operating Cash Flow

$10B

Beta

0.59

Next Earnings

N/A

Ex-Dividend

N/A

Next Dividend

N/A

Zen Score

Expand Score

High

Medium

Low

Industry average

Reasons for this score

NVO ($73.18) is trading below its intrinsic value of $128.90, according to Benjamin Graham's Formula from Chapter 14 of "The Intelligent Investor"

Valuation

NVO is good value based on its earnings relative to its share price (25.55x), compared to the US market average 31.52x)

Valuation

NVO is good value based on its earnings relative to its share price (25.55x), compared to the US Biotechnology industry average (-2.49x)

Valuation

NVO News

Valuation

NVO price to earnings (PE)

For valuing profitable companies with steady earnings

Company

25.55x

Industry

-2.49x

Market

31.52x

NVO is good value based on its earnings relative to its share price (25.55x), compared to the US market average 31.52x)

Valuation

NVO is good value based on its earnings relative to its share price (25.55x), compared to the US Biotechnology industry average (-2.49x)

Valuation

NVO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company

18.54x

Industry

10.93x

Market

56.65x

NVO is good value based on its book value relative to its share price (18.54x), compared to the US market average (56.65x)

Valuation

NVO is poor value based on its book value relative to its share price (18.54x), compared to the US Biotechnology industry average (10.93x)

Valuation

NVO price to earnings growth (PEG)

For valuing profitable companies with growth potential

NVO is poor value relative to its rate of earnings growth, measured by PEG ratio (3.14x)

Valuation

NVO's financial health

Profit margin

Revenue

$4.7B

Net Income

$1.6B

Profit Margin

33.7%

NVO's Earnings (EBIT) of $8.78B can safely cover interest payments on company debt ($641.25M)

Financials

NVO's profit margin has increased (+1.9%) in the last year from (32.5%) to (34.4%)

Financials

Assets to liabilities

Assets

$21.9B

Liabilities

$12.6B

Debt to equity

0.07

NVO's short-term assets ($11.51B) exceed its short-term liabilities ($11.09B)

Financials

NVO's short-term assets ($11.51B) exceed its long-term liabilities ($1.47B)

Financials

NVO's debt has increased relative to shareholder equity (1.35), over the past 5 years ago (0.98)

Financials

NVO's debt to equity ratio (1.35) is considered high

Financials

Cash flow

Operating

$1.1B

Investing

-$754.2M

Financing

-$1.4B

NVO's operating cash flow ($9.64B) is sufficient to service the company's debt ($641.25M)

Financials

Novo Nordisk A S Stock FAQ

What is Novo Nordisk A S's quote symbol?

(NYSE: NVO) Novo Nordisk A S trades on the NYSE under the ticker symbol NVO. Novo Nordisk A S stock quotes can also be displayed as NYSE: NVO.

How much is Novo Nordisk A S's stock price per share?

(NYSE: NVO) Novo Nordisk A S stock price per share is $73.18 today (as of Jan 25, 2021).

What is the 52 week high and low for Novo Nordisk A S (NYSE: NVO)?

(NYSE: NVO) Novo Nordisk A S's 52-week high was $73.92, and its 52-week low was $49.24. It is currently -1% from its 52-week high and 48.62% from its 52-week low.

What is Novo Nordisk A S's Market Cap?

(NYSE: NVO) Novo Nordisk A S's market cap is $172.55B, as of Jan 27, 2021.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Novo Nordisk A S's market cap is calculated by multiplying NVO's current stock price of $73.18 by NVO's total outstanding shares of 2,357,900,000.

How much is Novo Nordisk A S stock worth today?

(NYSE: NVO) Novo Nordisk A S currently has 2,357,900,000 outstanding shares. With Novo Nordisk A S stock trading at $73.18 per share, the total value of Novo Nordisk A S stock (market capitalization) is $172.55B.

Novo Nordisk A S stock was originally listed at a price of $2.89 in Dec 31, 1997. If you had invested in Novo Nordisk A S stock at $2.89, your return over the last 23 years would have been 2,436.57%, for an annualized return of 15.09%.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Zen Score

Reasons for this score

NVO News

Valuation

NVO price to earnings (PE)

For valuing profitable companies with steady earnings

NVO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

NVO price to earnings growth (PEG)

For valuing profitable companies with growth potential

NVO's financial health

Profit margin

Assets to liabilities

Cash flow

Novo Nordisk A S Stock FAQ

(NYSE: NVO) Novo Nordisk A S trades on the NYSE under the ticker symbol NVO. Novo Nordisk A S stock quotes can also be displayed as NYSE: NVO.

(NYSE: NVO) Novo Nordisk A S stock price per share is $73.18 today (as of Jan 25, 2021).

(NYSE: NVO) Novo Nordisk A S's 52-week high was $73.92, and its 52-week low was $49.24. It is currently -1% from its 52-week high and 48.62% from its 52-week low.

Company

Stocks

Social